Evropská unie - slovinština - EMA (European Medicines Agency)

sanofi winthrop industrie - cabazitaxel - prostatične neoplazme - antineoplastična sredstva - zdravilo jevtana v kombinaciji s prednizonom ali prednizolonom je indicirano za zdravljenje bolnikov z metastatskim rakom prostate, ki je hormonsko neodziven, predhodno zdravljenim z režimom, ki vsebuje docetaksel.

Evropská unie - slovinština - EMA (European Medicines Agency)

abbvie deutschland gmbh co. kg - ombitasvir, paritaprevir, ritonavir - hepatitis c, kronični - antivirusi za sistemsko uporabo - viekirax je naveden v kombinaciji z drugimi zdravili za zdravljenje kroničnega hepatitisa c (chc) pri odraslih. za virus hepatitisa c (hcv) genotip določene dejavnosti,.

Evropská unie - slovinština - EMA (European Medicines Agency)

gilead sciences ireland uc - bulevirtide acetate - hepatitis d, chronic - antivirusi za sistemsko uporabo - hepcludex is indicated for the treatment of chronic hepatitis delta virus (hdv) infection in plasma (or serum) hdv-rna positive adult patients with compensated liver disease.

Evropská unie - slovinština - EMA (European Medicines Agency)

accord healthcare s.l.u. - cabazitaxel - prostatic neoplazem, kastracija-odporne - antineoplastična sredstva - treatment of patients with hormone refractory metastatic prostate cancer previously treated with a docetaxel-containing regimen.

Slovinsko - slovinština - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

kabazitaksel - koncentrat za raztopino za infundiranje - kabazitaksel 10 mg / 1 ml - kabazitaksel

Slovinsko - slovinština - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

kabazitaksel - koncentrat za raztopino za infundiranje - kabazitaksel 10 mg / 1 ml - kabazitaksel

Slovinsko - slovinština - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

kabazitaksel - koncentrat za raztopino za infundiranje - kabazitaksel 10 mg / 1 ml - kabazitaksel

Evropská unie - slovinština - EMA (European Medicines Agency)

deciphera pharmaceuticals (netherlands) b.v. - ripretinib - gastrointestinalni stromalni tumorji - antineoplastična sredstva - qinlock is indicated for the treatment of adult patients with advanced gastrointestinal stromal tumour (gist) who have received prior treatment with three or more kinase inhibitors, including imatinib.

Evropská unie - slovinština - EMA (European Medicines Agency)

bioprojet pharma - pitolisant - sleep apnea, obstructive - druga zdravila na živčnem sistemu - ozawade is indicated to improve wakefulness and reduce excessive daytime sleepiness (eds) in adult patients with obstructive sleep apnoea (osa).

Evropská unie - slovinština - EMA (European Medicines Agency)

les laboratoires servier - ivosidenib - leukemia, myeloid, acute; cholangiocarcinoma - antineoplastična sredstva - tibsovo in combination with azacitidine is indicated for the treatment of adult patients with newly diagnosed acute myeloid leukaemia (aml) with an isocitrate dehydrogenase-1 (idh1) r132 mutation who are not eligible to receive standard induction chemotherapy (see section 5. tibsovo monotherapy is indicated for the treatment of adult patients with locally advanced or metastatic cholangiocarcinoma with an idh1 r132 mutation who were previously treated by at least one prior line of systemic therapy.